CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Tibor Stark

OPENALEX: A5064814933↗ORCID: 0000-0001-8118-9914↗

Affiliations

Organizations

Masaryk Universityauthorship · CZ Max Planck Institute of Neurobiologyauthorship · DE Max Planck Institute of Psychiatryauthorship · DE Max Planck Research Unit for Neurogeneticsauthorship · DE

Public evidence

4 connected articles

The Effects of Peripubertal THC Exposure in Neurodevelopmental Rat Models of Psychopathology.2023 · Europe PMC Early Blockade of CB1 Receptors Ameliorates Schizophrenia-like Alterations in the Neurodevelopmental MAM Model of Schizophrenia.2022 · Europe PMC Different effects of prenatal MAM vs. perinatal THC exposure on regional cerebral blood perfusion detected by Arterial Spin Labelling MRI in rats.2019 · Europe PMC HDAC1 and HDAC3 underlie dynamic H3K9 acetylation during embryonic neurogenesis and in schizophrenia-like animals.2018 · Europe PMC

Matched by exact identifiers only. Profile data: ORCID. Last retrieved 23/08/2026.

Tibor Stark - Medical Cannabis Research Engine